These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35065841)

  • 1. The effect of trans arterial chemoembolization in the management of intrahepatic cholangiocarcinoma. A systematic review and meta-analysis.
    Lv TR; Hu HJ; Liu F; Regmi P; Jin YW; Li FY
    Eur J Surg Oncol; 2022 May; 48(5):956-966. PubMed ID: 35065841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Transarterial Chemoembolization for Patients with Intrahepatic Cholangiocarcinoma after Surgical Resection: A Systematic Review and Meta-analysis.
    Wang L; Wen X; Zhuang L; Fang K; Shen J
    J Gastrointestin Liver Dis; 2022 Jun; 31(2):215-222. PubMed ID: 35574621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.
    He M; Jiang N; Yin X; Xu A; Mu K
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
    Shen WF; Zhong W; Liu Q; Sui CJ; Huang YQ; Yang JM
    World J Surg; 2011 Sep; 35(9):2083-91. PubMed ID: 21698503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization.
    Liu JB; Chu KJ; Ling CC; Wu TM; Wang HM; Shi Y; Li ZZ; Wang JH; Wu ZJ; Jiang XQ; Wang GR; Ma YS; Fu D
    Curr Probl Cancer; 2020 Dec; 44(6):100612. PubMed ID: 32517878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.
    Eltawil KM; Berry R; Abdolell M; Molinari M
    HPB (Oxford); 2012 May; 14(5):341-50. PubMed ID: 22487072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
    Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R
    Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
    Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
    Mumdzhiev N; Borisov B; Tenev R; Radicheva M
    Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
    Yang XG; Sun YY; Li DS; Xu GH; Huang XQ
    Front Immunol; 2022; 13():940009. PubMed ID: 35874708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Lv TR; Hu HJ; Ma WJ; Liu F; Jin YW; Li FY
    Eur J Surg Oncol; 2024 Jan; 50(1):107279. PubMed ID: 38000116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
    Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
    J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
    Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma.
    Yuan P; Song J; Wang F; Zhu G; Chen B
    Invest New Drugs; 2022 Oct; 40(5):1125-1132. PubMed ID: 35793038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.